GSTT1 Copy Number Gain and ZNF Overexpression Are Predictors of Poor Response to Imatinib in Gastrointestinal Stromal Tumors

Oncogenic mutations in gastrointestinal stromal tumors (GISTs) predict prognosis and therapeutic responses to imatinib. In wild-type GISTs, the tumor-initiating events are still unknown, and wild-type GISTs are resistant to imatinib therapy. We performed an association study between copy number alte...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Lee, Eui Jin, Kang, Guhyun, Kang, Shin Woo, Jang, Kee-Taek, Lee, Jeeyun, Park, Joon Oh, Park, Cheol Keun, Sohn, Tae Sung, Kim, Sung, Kim, Kyoung-Mee
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2013
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3790698/
https://ncbi.nlm.nih.gov/pubmed/24124608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0077219
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak